Lyme disease classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(5 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Lyme disease}}
{{Lyme disease}}
{{CMG}}{{AE}}{{Anmol}}
{{CMG}}; {{AE}} {{Anmol}}
==Overview==
==Overview==
[[Lyme disease]] can be classified into three stages. The first stage is localized [[Lyme disease]], the second is [[Disseminated disease|disseminated]] [[Lyme disease]], and the third is late [[Disseminated disease|disseminated]] [[Lyme disease]]. During stage 1, the patient can develop [[erythema migrans]] [[rash]]. Ten to twenty percent of the patients who have [[Lyme disease]] can develop post treatment [[Lyme disease]] syndrome. There are various genospecies of ''[[Borrelia burgdorferi]]'' sensu lato complex that can cause [[Lyme Disease|Lyme disease]]. A novel [[spirochete]], ''[[Borrelia mayonii]]'', has been recently discovered to be responsible for [[Lyme disease]].
[[Lyme disease]] can be classified into three stages. The first stage is localized [[Lyme disease]], the second is [[Disseminated disease|disseminated]] [[Lyme disease]], and the third is late [[Disseminated disease|disseminated]] [[Lyme disease]]. During stage 1, the patient can develop [[erythema migrans]] [[rash]]. Ten to twenty percent of the patients who have [[Lyme disease]] can develop post treatment [[Lyme disease]] syndrome. There are various genospecies of ''[[Borrelia burgdorferi]]'' sensu lato complex that can cause [[Lyme Disease|Lyme disease]]. A novel [[spirochete]], ''[[Borrelia mayonii]]'', has been recently discovered to be responsible for [[Lyme disease]].
Line 13: Line 13:


===Classification based on causative organism===
===Classification based on causative organism===
*The majority of cases of [[Lyme disease]] are caused by ''[[Borrelia burgdorferi]]'' sensu lato (s.l.) complex. There around 18 genospecies in ''[[Borrelia burgdorferi]]'' sensu lato (s.l.) complex. Out of these, only 7 infect humans (3 commonly and 4 occasionally).<ref name="pmid21890064">{{cite journal| author=Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH| title=Updates on Borrelia burgdorferi sensu lato complex with respect to public health. | journal=Ticks Tick Borne Dis | year= 2011 | volume= 2 | issue= 3 | pages= 123-8 | pmid=21890064 | doi=10.1016/j.ttbdis.2011.04.002 | pmc=3167092 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21890064  }}</ref>
*The majority of cases of [[Lyme disease]] are caused by ''[[Borrelia burgdorferi]]'' sensu lato (s.l.) complex. There are 18 genospecies in ''[[Borrelia burgdorferi]]'' sensu lato (s.l.) complex. Out of these, only 7 infect humans (genotype 3 commonly and 4 occasionally).<ref name="pmid21890064">{{cite journal| author=Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH| title=Updates on Borrelia burgdorferi sensu lato complex with respect to public health. | journal=Ticks Tick Borne Dis | year= 2011 | volume= 2 | issue= 3 | pages= 123-8 | pmid=21890064 | doi=10.1016/j.ttbdis.2011.04.002 | pmc=3167092 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21890064  }}</ref>
{|
{|
! style="width: 80px; background: #4479BA; text-align: center;" colspan="3" |{{fontcolor|#FFF||''Borrelia burgdorferi'' sensu lato (s.l.) complex genospecies}}
! colspan="3" style="width: 80px; background: #4479BA; text-align: center;" |{{fontcolor|#FFF||''Borrelia burgdorferi'' sensu lato (s.l.) complex genospecies}}
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" colspan="2" |'''Pathogenic'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pathogenic'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Non-Pathogenic'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Non-Pathogenic'''
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Commonly infects humans
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Commonly infect humans
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Rare/no human infection
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Rare (no human infection)
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not yet isolated from humans
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not isolated from humans yet
|-
|-
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
Line 93: Line 93:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Bacterial diseases]]
[[Category:Bacterial diseases]]
Line 100: Line 103:
[[Category:Spirochaetes]]
[[Category:Spirochaetes]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
 
[[Category:Up-To-Date]]
{{WikiDoc Help Menu}}
[[Category:Infectious disease]]
{{WikiDoc Sources}}
[[Category:Ophthalmology]]
[[Category:Neurology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]

Latest revision as of 22:34, 29 July 2020

Lyme disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology and Demographics

Causes

Differentiating Lyme disease from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Sudies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Lyme disease classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lyme disease classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lyme disease classification

CDC on Lyme disease classification

Lyme disease classification in the news

Blogs on Lyme disease classification

Directions to Hospitals Treating Lyme disease

Risk calculators and risk factors for Lyme disease classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Lyme disease can be classified into three stages. The first stage is localized Lyme disease, the second is disseminated Lyme disease, and the third is late disseminated Lyme disease. During stage 1, the patient can develop erythema migrans rash. Ten to twenty percent of the patients who have Lyme disease can develop post treatment Lyme disease syndrome. There are various genospecies of Borrelia burgdorferi sensu lato complex that can cause Lyme disease. A novel spirochete, Borrelia mayonii, has been recently discovered to be responsible for Lyme disease.

Classification

Classification based on clinical stage

  • Stage 1 is called early localized Lyme disease. The infection is not yet widespread throughout the body.
  • Stage 2 is called early disseminated Lyme disease. The bacteria have begun to spread throughout the body.
  • Stage 3 is called late disseminated Lyme disease. The bacteria have spread throughout the body.

Classification based on causative organism

Borrelia burgdorferi sensu lato (s.l.) complex genospecies
Pathogenic Non-Pathogenic
Commonly infect humans Rare (no human infection) Not isolated from humans yet
  • B. bavariensis
  • B. bissettii
  • B. kurtenbachii
  • B. lusitaniae
  • B. spielmanii
  • B. valaisiana
  • B. americana
  • B. andersonii
  • B. californiensis
  • B. carolinensis
  • B. japonica
  • B. tanukii
  • B. turdi
  • B. sinica
  • B. yangtze
  • However, B. mayonii has recently been discovered to be responsible for development of Lyme disease.[2]
  • The following table demonstrates key clinical and epidemiological features that distinguish B. burgdorferi from B. mayonii:
General information B. burgdorferi B. mayonii

Transmission Tick bite Tick bite
Distribution in the USA Northeast, Mid-Atlantic, and Midwest regions Midwest region
Bacteria Concentration in Blood (Spirochetemia) Lower Higher
Early Symptoms Fever, headache, rash, neck pain Fever, headache, rash, neck pain
Late Symptoms and Complications Joint pain and arthritis Joint pain and arthritis
Nausea / Vomiting? No Yes
Rash Characteristics Bullseye target lesion Diffuse rash
Diagnosis Serology or PCR Serology or PCR
Treatment Doxycycline Doxycycline

References

  1. Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH (2011). "Updates on Borrelia burgdorferi sensu lato complex with respect to public health". Ticks Tick Borne Dis. 2 (3): 123–8. doi:10.1016/j.ttbdis.2011.04.002. PMC 3167092. PMID 21890064.
  2. Pritt, Bobbi S; Mead, Paul S; Johnson, Diep K Hoang; Neitzel, David F; Respicio-Kingry, Laurel B; Davis, Jeffrey P; Schiffman, Elizabeth; Sloan, Lynne M; Schriefer, Martin E; Replogle, Adam J; Paskewitz, Susan M; Ray, Julie A; Bjork, Jenna; Steward, Christopher R; Deedon, Alecia; Lee, Xia; Kingry, Luke C; Miller, Tracy K; Feist, Michelle A; Theel, Elitza S; Patel, Robin; Irish, Cole L; Petersen, Jeannine M (2016). "Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study" (PDF). The Lancet Infectious Diseases. 16 (5): 556–564. doi:10.1016/S1473-3099(15)00464-8. ISSN 1473-3099.


Template:WikiDoc Sources